Ticker
VRCACompany Name
VERRICA PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Free Cash Flow | Free Cash Flow Yield | Market Capitalization |
---|---|---|---|
6/30/2025 | $ -47.35M | -73.5% | $ 64.42M |
3/31/2025 | $ -53.68M | -105.52% | $ 50.87M |
12/31/2024 | $ -60.95M | -102.44% | $ 59.49M |
9/30/2024 | $ -59.62M | -163.95% | $ 36.37M |
6/30/2024 | $ -65.93M | -49.52% | $ 133.13M |
3/31/2024 | $ -54.28M | -13.39% | $ 405.54M |
12/31/2023 | $ -38.94M | -17.42% | $ 223.55M |
9/30/2023 | $ -29.23M | -21.64% | $ 135.03M |
6/30/2023 | $ -12.6M | -5.66% | $ 222.52M |
3/31/2023 | $ -15.21M | -5.54% | $ 274.4M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / Market Cap
(=) FCF Yield
FCF Yield for VERRICA PHARMACEUTICALS INC is calculated as follows: FCF [ $ -33.25M ] / Market Cap [ $ 202.79M ]
(=) FCF Yield [ -16.4% ]
Minimum
Sep 30, 2024
Maximum
Mar 31, 2023
Average
Median
filtered constituents | 3.58K |
---|---|
min | -33.87% |
max | 37.55% |
average | 1.59% |
median | 3.22% |
std | 11.38% |